The role of Heparin-binding proteins in normal pancreas and acute pancreatitis



Nunes, Quentin ORCID: 0000-0002-7513-8595
The role of Heparin-binding proteins in normal pancreas and acute pancreatitis. PhD thesis, University of Liverpool.

[thumbnail of NunesQuen Jan2015 2009329.pdf] Text
NunesQuen Jan2015 2009329.pdf - Unspecified
Available under License Creative Commons Attribution.

Download (3MB)
[thumbnail of Suppl 1 NP Mouse 2 Peps.xls] Text
Suppl 1 NP Mouse 2 Peps.xls - Unspecified
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (243kB) | Request a copy
[thumbnail of Suppl 2 AP Mouse 2 Peps.xls] Text
Suppl 2 AP Mouse 2 Peps.xls - Unspecified
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (277kB) | Request a copy
[thumbnail of Suppl 3 NP HBP list.xls] Text
Suppl 3 NP HBP list.xls - Unspecified
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (76kB) | Request a copy
[thumbnail of Suppl 4 AP HBP list.xls] Text
Suppl 4 AP HBP list.xls - Unspecified
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (78kB) | Request a copy
[thumbnail of Suppl 5 AP List Overexpressed HBPs .xls] Text
Suppl 5 AP List Overexpressed HBPs .xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (105kB) | Request a copy
[thumbnail of Suppl 6 AP List Underexpressed HBPs.xls] Text
Suppl 6 AP List Underexpressed HBPs.xls - Unspecified
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (91kB) | Request a copy
[thumbnail of Suppl 7 NP Canonical Paths.xls] Text
Suppl 7 NP Canonical Paths.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (61kB) | Request a copy
[thumbnail of Suppl 8 AP Canonical Paths.xls] Text
Suppl 8 AP Canonical Paths.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (169kB) | Request a copy
[thumbnail of Suppl 9 NP Diseases and Functions.xls] Text
Suppl 9 NP Diseases and Functions.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (169kB) | Request a copy
[thumbnail of Suppl 10 AP Diseases and functions.xls] Text
Suppl 10 AP Diseases and functions.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (186kB) | Request a copy
[thumbnail of Suppl 11 NP Unique HBPs.xls] Text
Suppl 11 NP Unique HBPs.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (18kB) | Request a copy
[thumbnail of Suppl 12 AP Unique HBPs.xls] Text
Suppl 12 AP Unique HBPs.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (20kB) | Request a copy
[thumbnail of Suppl 13 NP Unique HBPs Canonical Paths.xls] Text
Suppl 13 NP Unique HBPs Canonical Paths.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (41kB) | Request a copy
[thumbnail of Suppl 14 AP Unique HBPs Canonical Paths.xls] Text
Suppl 14 AP Unique HBPs Canonical Paths.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (53kB) | Request a copy
[thumbnail of Suppl 15 NP Unique HBPs Diseases and Mol functions.xls] Text
Suppl 15 NP Unique HBPs Diseases and Mol functions.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (115kB) | Request a copy
[thumbnail of Suppl 16 AP Unique HBPs Diseases and Functions.xls] Text
Suppl 16 AP Unique HBPs Diseases and Functions.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (131kB) | Request a copy
[thumbnail of Suppl 17 AP Top Clusters.xls] Text
Suppl 17 AP Top Clusters.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (114kB) | Request a copy
[thumbnail of Suppl 18 NEW Global HBP List.xls] Text
Suppl 18 NEW Global HBP List.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (123kB) | Request a copy
[thumbnail of Suppl 19 New Global HBP List Canonical Paths.xls] Text
Suppl 19 New Global HBP List Canonical Paths.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (67kB) | Request a copy
[thumbnail of Suppl 20 New Global HBP List Diseases and Functions.xls] Text
Suppl 20 New Global HBP List Diseases and Functions.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (372kB) | Request a copy
[thumbnail of Suppl 1 NP Mouse 2 Peps.xls] Text
Suppl 1 NP Mouse 2 Peps.xls - Supporting information
Access to this file is embargoed until Unspecified.
After the embargo period this will be available under License Creative Commons Attribution.

Download (243kB) | Request a copy

Abstract

Acute pancreatitis (AP) is a leading cause for hospitalisation and has significant quality of life implications for the patient and cost implications for the National Health Service. Although most episodes of AP are mild and self-limiting, the severe form of the disease is associated with a high mortality. In the absence of definitive treatment, management is mainly supportive. There is an urgent need to develop more effective biomarkers and drugs to manage AP. Genome-wide studies have demonstrated that proteins that bind to heparin (HBPs) form highly interconnected networks which are functionally important in health and disease. It was hypothesized that this is true in the pancreas and in AP. Testing this hypothesis, using mRNA as a proxy for protein, it was shown that HBPs constitute an important extracellular sub-proteome within the normal pancreas and in major pancreatic diseases that is likely to provide a rich repository of potential biomarkers and drug targets. Building upon this work, a proteomic analysis of HBPs in normal pancreas (NP) and in caerulein-induced mouse AP was undertaken. This has more than doubled the number of HBPs to 883, with 460 new HBPs identified. These may represent the most interconnected set of extracellular proteins and therefore with the greatest regulatory potential. Non canonical HBPs such as NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFA9, NDUFA10, NDUFA9 and NDUFA10 were identified and found to be underexpressed in AP as compared to NP. These may have potential moonlighting roles, not previously known. By virtue of being extracellular and binding to heparin, HBPs are accessible and are potential biomarkers and drug targets in AP. In addition to identifying existing biomarkers in AP such as pancreatic amylase, a number of HBPs with biomarkers potential such as HRG, CD14 and FN1 were identified and need further investigation. HBPs such as SERPINC1, VEGFA and PIP5K1C need further evaluation in drug development. These along with modified heparins, heparin mimetics and matrix therapy in AP provide exciting areas for future research.

Item Type: Thesis (PhD)
Additional Information: Date: 2015-01 (completed)
Subjects: ?? R1 ??
?? RM ??
Depositing User: Symplectic Admin
Date Deposited: 27 Aug 2015 10:04
Last Modified: 17 Dec 2022 01:34
DOI: 10.17638/02009329
URI: https://livrepository.liverpool.ac.uk/id/eprint/2009329